BiotechTube
Home/AiViva BioPharma/Agustin de la Calle, PhD
AD

Agustin de la Calle, PhD

Vice President, Business Development

AiViva BioPharma

Therapeutic Areas

DermatologyOphthalmologyOncologyUrology

AiViva BioPharma Pipeline

DrugIndicationPhase
AIV001 (axitinib)Nodular and Superficial Basal Cell Carcinoma (Nonmelanoma Skin Cancer)Phase 2

Leadership Team at AiViva BioPharma

DT
Diane Tang-Liu, PhD
President & Chief Executive Officer
DD
Darlene Deecher, PhD
Vice President, Clinical Development
DS
Del Stagg, PhD
Vice President, Regulatory Affairs
JW
Jinn Wu, PhD
Chairman of the Board
View full AiViva BioPharma profile